Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
- Revenue in USD (TTM)6.47bn
- Net income in USD555.41m
- Incorporated1919
- Employees29.30k
- LocationOlympus Corp2951, Ishikawa-machiHACHIOJI-SHI 192-8507JapanJPN
- Phone+81 426422111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein Inc | 12.94bn | 391.00m | 9.20bn | 25.00k | 24.70 | 2.76 | 13.04 | 0.7115 | 3.17 | 3.17 | 104.73 | 28.35 | 1.19 | 4.86 | 7.60 | 517,520.00 | 3.70 | 5.43 | 6.36 | 9.19 | 31.19 | 30.23 | 3.10 | 3.98 | 0.7885 | 6.59 | 0.3872 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Baxter International Inc | 11.02bn | -355.00m | 10.18bn | 38.00k | -- | 1.40 | 16.08 | 0.9237 | -0.6925 | -0.6654 | 21.46 | 14.09 | 0.4618 | 3.14 | 6.08 | 290,078.90 | -1.48 | -0.8441 | -1.87 | -1.03 | 35.05 | 38.63 | -3.20 | -2.03 | 1.18 | 3.42 | 0.5684 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 1.60 |
| Revvity Inc | 2.86bn | 239.88m | 10.89bn | 11.00k | 46.36 | 1.50 | 16.87 | 3.81 | 2.07 | 2.08 | 24.49 | 63.95 | 0.2326 | 3.46 | 4.15 | -- | 1.95 | 3.23 | 2.13 | 3.58 | 54.77 | 58.48 | 8.40 | 13.58 | 1.40 | 5.23 | 0.3075 | 8.52 | 3.67 | -5.47 | -15.26 | -19.91 | -1.05 | 0.00 |
| Globus Medical Inc | 2.77bn | 423.78m | 11.79bn | 5.30k | 28.47 | 2.70 | 16.84 | 4.26 | 3.09 | 3.09 | 20.09 | 32.68 | 0.5441 | 1.29 | 4.59 | 522,604.50 | 8.32 | 4.70 | 9.53 | 5.18 | 65.34 | 66.40 | 15.30 | 9.73 | 2.47 | 15.96 | 0.0002 | 0.00 | 60.62 | 26.25 | -16.19 | -7.88 | 10.29 | -- |
| Solventum Corp | 8.40bn | 1.52bn | 13.10bn | 22.00k | 8.69 | 2.63 | 6.41 | 1.56 | 8.69 | 8.69 | 48.01 | 28.75 | 0.5851 | 3.85 | 7.91 | 381,909.10 | 10.61 | -- | 13.32 | -- | 54.18 | -- | 18.13 | -- | 1.14 | 1.76 | 0.5075 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Penumbra Inc | 1.33bn | 164.03m | 13.31bn | 4.50k | 81.87 | 9.78 | 73.37 | 9.98 | 4.14 | 4.14 | 33.63 | 34.70 | 0.8276 | 1.07 | 7.42 | 296,399.60 | 10.18 | 1.42 | 11.31 | 1.58 | 66.80 | 63.21 | 12.30 | 1.96 | 4.18 | -- | 0.0171 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Align Technology Inc | 4.03bn | 410.35m | 13.40bn | 20.95k | 33.01 | 3.31 | 32.68 | 3.32 | 5.66 | 5.66 | 55.58 | 56.43 | 0.6483 | 5.33 | 3.85 | -- | 6.59 | 8.11 | 9.67 | 11.97 | 68.25 | 70.40 | 10.17 | 12.31 | 1.24 | -- | -- | -- | 0.899 | 10.30 | -2.61 | -25.40 | -- | -- |
| Guardant Health Inc | 902.57m | -398.79m | 13.51bn | 2.00k | -- | -- | -- | 14.97 | -3.21 | -3.21 | 7.27 | -2.84 | 0.6411 | 4.02 | 8.85 | 451,510.30 | -28.33 | -24.20 | -33.49 | -26.83 | 63.76 | 63.23 | -44.18 | -91.24 | 3.12 | -10.70 | 1.47 | -- | 31.04 | 28.08 | 8.98 | -- | 10.58 | -- |
| Olympus Corp - ADR | 6.47bn | 555.41m | 13.52bn | 29.30k | 22.52 | 2.42 | 13.52 | 2.09 | 0.4952 | 0.4954 | 5.78 | 4.60 | 0.6894 | 1.62 | 5.12 | 220,767.10 | 5.92 | -- | 8.27 | -- | 66.24 | 66.85 | 8.59 | 10.69 | 1.09 | 21.23 | 0.2352 | -- | 6.53 | 5.72 | 342.69 | 14.22 | -- | -- |
| Cooper Companies Inc | 4.09bn | 374.90m | 16.26bn | 15.00k | 44.29 | 1.97 | 21.62 | 3.97 | 1.87 | 1.87 | 20.46 | 42.06 | 0.3312 | 1.71 | 5.29 | 272,826.70 | 3.03 | 8.04 | 3.32 | 8.86 | 65.54 | 66.01 | 9.16 | 24.66 | 1.13 | 6.32 | 0.2332 | 0.2049 | 5.06 | 10.98 | -4.44 | 9.48 | 3.15 | -- |
| Hologic Inc | 4.13bn | 543.80m | 16.75bn | 7.07k | 31.14 | 3.19 | 19.96 | 4.06 | 2.41 | 2.41 | 18.28 | 23.51 | 0.4608 | 2.57 | 6.79 | 583,663.40 | 6.07 | 11.22 | 6.82 | 12.85 | 56.51 | 60.20 | 13.18 | 21.99 | 3.32 | 15.76 | 0.3246 | 0.00 | 1.74 | 1.66 | -28.35 | -12.69 | -0.5168 | -- |
| Insulet Corp | 2.52bn | 246.20m | 17.08bn | 3.90k | 70.43 | 12.34 | 51.17 | 6.77 | 3.45 | 3.45 | 34.85 | 19.68 | 0.833 | 1.62 | 6.02 | 646,641.00 | 8.13 | 6.00 | 10.05 | 7.03 | 71.46 | 67.05 | 9.76 | 9.22 | 2.18 | 27.39 | 0.423 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
| Illumina Inc | 4.34bn | 850.00m | 17.86bn | 8.60k | 21.32 | 6.56 | 15.95 | 4.11 | 5.48 | 5.48 | 27.88 | 17.80 | 0.6709 | 2.61 | 5.34 | 505,000.00 | 13.13 | -10.15 | 17.32 | -12.15 | 66.61 | 65.39 | 19.57 | -23.18 | 1.72 | 15.79 | 0.4221 | -- | -0.6633 | 6.04 | 169.50 | 5.32 | -4.77 | -- |
| West Pharmaceutical Services Inc | 3.07bn | 493.70m | 18.04bn | 10.60k | 36.87 | 5.68 | 27.72 | 5.87 | 6.79 | 6.79 | 42.28 | 44.11 | 0.7769 | 4.80 | 5.46 | -- | 12.11 | 15.24 | 14.29 | 18.19 | 35.91 | 37.89 | 15.59 | 18.67 | 2.34 | -- | 0.06 | 9.99 | 6.25 | 7.44 | 0.203 | 7.36 | 10.39 | 5.51 |
| Zimmer Biomet Holdings Inc | 8.23bn | 705.00m | 19.11bn | 17.00k | 27.20 | 1.50 | 10.63 | 2.32 | 3.55 | 3.55 | 41.42 | 64.11 | 0.3703 | 1.10 | 5.17 | -- | 3.17 | 3.03 | 3.58 | 3.46 | 69.71 | 71.01 | 8.56 | 9.10 | 1.10 | 4.74 | 0.3718 | 29.10 | 7.20 | 6.08 | -21.98 | -- | 9.26 | 0.00 |
Data as of Feb 13 2026. Currency figures normalised to Olympus Corp's reporting currency: US Dollar USD
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Investment Management Business Trustas of 06 Feb 2026 | 55.27k | 0.01% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 9.49k | 0.00% |
| GAMMA Investing LLCas of 31 Dec 2025 | 2.05k | 0.00% |
| Ramirez Asset Management, Inc.as of 31 Dec 2025 | 1.59k | 0.00% |
| Salomon & Ludwin LLCas of 31 Dec 2025 | 758.00 | 0.00% |
| IMA Advisory Services, Inc.as of 31 Dec 2025 | 72.00 | 0.00% |
| PNC Wealth Management LLCas of 31 Dec 2025 | 14.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
